Precigen (PGEN) Projected to Post Earnings on Tuesday

Precigen (NASDAQ:PGEN) will likely be releasing its earnings data before the market opens on Tuesday, March 18th. Analysts expect Precigen to post earnings of ($0.06) per share and revenue of $1.30 million for the quarter.

Precigen Stock Down 4.8 %

PGEN stock opened at $1.77 on Tuesday. Precigen has a 52-week low of $0.65 and a 52-week high of $2.17. The stock’s fifty day simple moving average is $1.50 and its 200-day simple moving average is $1.11. The stock has a market capitalization of $518.38 million, a price-to-earnings ratio of -3.22 and a beta of 1.58.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on PGEN. JMP Securities restated a “market outperform” rating and set a $5.00 price objective on shares of Precigen in a report on Tuesday, January 14th. HC Wainwright reaffirmed a “buy” rating and issued a $6.00 target price (up from $4.00) on shares of Precigen in a research report on Thursday, January 23rd. Two analysts have rated the stock with a sell rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $7.00.

About Precigen

Precigen, Inc operates as a discovery and clinical-stage biopharmaceutical company that develops gene and cell therapies using precision technology to target diseases in therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar.